iSOFT Wins 2010 European Business Analytics Systems Competitive Strategy Leadership Award

iSOFTiSOFT Group Limited, one of the world's largest healthcare information technology companies, has received the Frost and Sullivan, 2010 European Business Analytics Systems Competitive Strategy Leadership Award.

HiNT is a powerful business analytics tool designed to empower modern healthcare organisations with business-critical information. By consolidating data from all the various applications within an organisation, users can view and explore information, trends and performance indicators covering all aspects of service delivery and financial performance. Designed around the latest clinical coding standards and with prebuilt reporting dashboards covering clinical activity, administration, finance and performance, Health Intelligence was seen as the market leader by Frost & Sullivan, and the clear winner for this award.

For the Competitive Strategy Leadership Award, the following criteria were used to benchmark iSOFT's performance against key competitors:

  • Leverage of competitive intelligence
  • Execution of competitive strategy
  • Impact on market share
  • Competitive brand positioning (brand strength and unique market position)
  • Impact on customer satisfaction/value

Through the overall product strategy, management and marketing, this award recognises iSOFT's growing market share and ongoing commitment to the healthcare sector.

The award was presented to Eamonn Morris, Managing Director of iSOFT Business Solutions, at a gala awards dinner in London on 19 May. Eamonn Morris said: "This is a significant achievement for iSOFT and illustrates the power and uniqueness of the iSOFT Health Intelligence solution, HiNT. Since taking the solution to market in late 2009, we have seen a huge interest from clients, prospects and partners in all territories across the globe. At iSOFT we have a dream, which is enhancing lives through innovative healthcare solutions; HiNT is a prime example of where iSOFT have designed and developed a solution which will add value to healthcare organisations worldwide, providing administrative, financial and clinical intelligence to enable informed decisions regarding the management and delivery of healthcare."

Frost & Sullivan acknowledges iSOFT's significant investments in research and development to improve the organisation's position, commenting, "iSOFT places more emphasis on providing user-friendly and efficient information and analytic solutions for its healthcare customers. Hundreds of hospitals have adopted iSOFT's healthcare information systems, as they offer greater return on investment."

A global network of iSOFT subsidiaries and partner networks provides significant support to the national healthcare markets, offering customers a complete suite of solutions and services around the world.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organizations.

Today, more than 13,000 provider organizations in about 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

About Frost and Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages almost 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit www.frost.com.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...